 impact breakthrough clinical trials survival population tumor registries statistical models impact clinical trials MOPP Hodgkin disease PVB disseminated testicular cancer survival Connecticut tumor registry National Cancer Institute Surveillance Epidemiology End Results SEER registry program segmented regression model conjunction Cox semi-parametric proportional hazards model parametric Weibull exponential cure models models survival improved treatments available long survival full population survival impact addition degree parametric models survival improvements parametric family Results modelling indicate dissemination years Hodgkin disease years disseminated testicular cancer disease survival first broke prior trends time breakthrough trial publication successful 'precursor trials combination chemotherapy improved population survival trends Reasons difference dissemination time cancer sites order factors responsible speed dissemination effective utilization new therapies